Consistent with this finding, serum TARC levels in SSc patients with ILD were significantly higher compared with those without ILD (636.1 ± 412.3 pg/mL vs. 391.7 ± 221.0 pg/mL, p = 0.010; Figure 2). Here, CCL17 is linked to systemic sclerosis.